NovaBay Pharmaceuticals, Inc. (NBY)

NYSE American - Nasdaq Precio en tiempo real. Divisa en USD.

Añadir a la lista de seguimiento

0.0892

+0.0084

(+10.40%)

A partir del 03:20PM EDT. Mercado abierto.

Accionistas principales

Nómina de miembros de la gerencia

Transacciones de miembros de la gerencia

Divisa en USD

Compras de miembros de la gerencia en los últimos 6 meses	Acciones	Trans
Compras	0	0
Ventas	N/D	0
Acciones netas compradas (vendidas)	0	0
Acciones totales pertenecientes a miembros de la gerencia	9.33k	N/D
Acciones netas compradas (vendidas) en %	N/D	N/D

Compras institucionales netas del trimestre anterior al último	Acciones
Acciones netas compradas (vendidas)	N/D
Cambio en acciones institucionales propias en %	N/D

Información confidencial de transacciones reportada (últimos dos años)

Miembro de la gerencia	Transacción	Tipo	Valor	Fecha	Acciones
FREIMAN PAUL EDWARD Director		Directo		11 may 2023	858
ZHENG JEFF YENYOU Director		Directo		11 may 2023	858
WU MIJIA Director		Directo		11 may 2023	858
GARLIKOV JULIE Director		Directo		11 may 2023	858
SIT SWAN Director		Directo		11 may 2023	858
ZHENG YONGXIANG Director		Directo		11 may 2023	858
KUNIN JEFFREY Officer	Sale at price 1.81 per share.	Indirecto	2	06 dic 2022	1
KUNIN AUDREY Officer	Sale at price 1.81 per share.	Indirecto	2	06 dic 2022	1
KUNIN JEFFREY Officer	Sale at price 2.10 per share.	Indirecto	12,545	21 nov 2022	5,960
KUNIN JEFFREY Officer	Sale at price 2.10 per share.	Indirecto	12,545	21 nov 2022	5,960
KUNIN AUDREY Officer and Director	Sale at price 2.10 per share.	Indirecto	12,545	21 nov 2022	5,960
KUNIN AUDREY Officer	Sale at price 2.10 per share.	Indirecto	12,545	21 nov 2022	5,960
HALL JUSTIN M Chief Executive Officer	Purchase at price 0.15 per share.	Directo	1,500	14 sept 2022	10,000
KUNIN JEFFREY Officer	Sale at price 0.16 per share.	Indirecto	46,094	14 sept 2022	291,368
KUNIN AUDREY Officer and Director	Sale at price 0.16 per share.	Indirecto	46,094	14 sept 2022	291,368
FREIMAN PAUL EDWARD Director		Directo		20 may 2022	30,000
ZHENG JEFF YENYOU Director		Directo		20 may 2022	30,000
WU MIJIA Director		Directo		20 may 2022	30,000
SIT SWAN Director		Directo		20 may 2022	30,000
HALL JUSTIN M Chief Executive Officer	Purchase at price 0.43 per share.	Directo	30,000	06 dic 2021	69,767
JONES ANDREW D. Chief Financial Officer	Purchase at price 0.01 per share.	Directo	554	06 dic 2021	45,455
KUNIN JEFFREY Officer	Purchase at price 0.46 per share.	Indirecto	47,013	03 dic 2021	101,650
KUNIN AUDREY Officer	Purchase at price 0.46 per share.	Indirecto	47,013	03 dic 2021	101,650
KUNIN JEFFREY Officer	Purchase at price 0.48 per share.	Indirecto	124,888	02 dic 2021	262,369
KUNIN AUDREY Officer	Purchase at price 0.48 per share.	Indirecto	124,888	02 dic 2021	262,369
KUNIN JEFFREY Officer	Purchase at price 0.49 per share.	Indirecto	7,276	01 dic 2021	14,848
KUNIN AUDREY Officer	Purchase at price 0.49 per share.	Indirecto	7,276	01 dic 2021	14,848
KUNIN JEFFREY Officer	Purchase at price 0.46 per share.	Indirecto	13,800	30 nov 2021	30,000
KUNIN AUDREY Officer	Purchase at price 0.46 per share.	Indirecto	13,800	30 nov 2021	30,000
KUNIN JEFFREY Officer	Purchase at price 0.46 per share.	Indirecto	41,868	23 nov 2021	91,133
KUNIN AUDREY Officer	Purchase at price 0.46 per share.	Indirecto	41,868	23 nov 2021	91,133
WU MIJIA Director	Stock Award(Grant) at price 0.30 per share.	Directo	6,000	17 ago 2020	20,000
WU MIJIA Director	Sale at price 1.35 per share.	Directo	27,000	17 ago 2020	20,000
WU MIJIA Director	Conversion of Exercise of derivative security at price 56.70 per share.	Directo	1,134,000	17 ago 2020	20,000
FU JIAN PING Beneficial Owner of more than 10% of a Class of Security	Sale at price 1.23 per share.	Directo	1,601,890	31 jul 2020	1,302,350
SIECZKAREK MARK M. Former		Directo		30 jul 2019	167,938
PIONEER PHARMA HONG KONG CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 4.04 per share.	Directo	98,277	11 jun 2019	24,326
WU MIJIA Director	Sale at price 2.03 - 4.04 per share.	Indirecto	160,793	11 jun 2019	63,492
FU JIAN PING Beneficial Owner of more than 10% of a Class of Security	Sale at price 3.84 per share.	Directo	1,462,863	11 jun 2019	380,954
RALEIGH JASON PHILIP Chief Financial Officer	Sale at price 3.00 - 3.75 per share.	Directo	106,778	11 jun 2019	33,155
RALEIGH JASON PHILIP Chief Financial Officer	Conversion of Exercise of derivative security at price 2.20 - 2.35 per share.	Directo	74,404	11 jun 2019	33,155
HALL JUSTIN M Chief Executive Officer	Stock Award(Grant) at price 3.10 per share.	Directo	147,250	10 jun 2019	47,500
HALL JUSTIN M Chief Executive Officer	Sale at price 3.03 per share.	Directo	143,925	10 jun 2019	47,500
HALL JUSTIN M Chief Executive Officer	Conversion of Exercise of derivative security at price 2.02 per share.	Directo	95,950	10 jun 2019	47,500
HALL JUSTIN M General Counsel	Conversion of Exercise of derivative security at price 3.10 per share.	Directo	147,250	10 jun 2019	47,500
RALEIGH JASON PHILIP Chief Financial Officer	Conversion of Exercise of derivative security at price 3.10 per share.	Directo	72,556	10 jun 2019	23,405
HALL JUSTIN M General Counsel	Conversion of Exercise of derivative security at price 2.78 per share.	Directo	55,600	18 sept 2017	20,000
FU JIAN PING Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 3.15 per share.	Directo	400,003	11 oct 2016	126,985
SIECZKAREK MARK M. Chief Executive Officer	Conversion of Exercise of derivative security at price 1.91 per share.	Directo	522,284	30 sept 2016	273,447
WU MIJIA Director	Conversion of Exercise of derivative security at price 3.15 per share.	Directo	50,000	30 sept 2016	15,873
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 1.81 per share.	Directo	328,153	22 sept 2016	181,300
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 1.91 per share.	Directo	2,500,003	22 sept 2016	1,308,902
FU JIAN PING Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 1.91 per share.	Directo	1,850,001	22 sept 2016	968,587
SIECZKAREK MARK M. Chief Executive Officer	Stock Award(Grant) at price 1.91 per share.	Directo	500,000	01 ago 2016	261,780
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 1.91 per share.	Directo	2,500,001	01 ago 2016	1,308,901
SIECZKAREK MARK M. Director	Stock Award(Grant) at price 1.91 per share.	Directo	500,000	09 may 2016	261,780
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 1.91 per share.	Directo	2,500,001	09 may 2016	1,308,901
FU JIAN PING Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 1.91 per share.	Directo	3,700,000	09 may 2016	1,937,173
SIECZKAREK MARK M. Director	Stock Award(Grant) at price 1.91 per share.	Directo	239,489	25 feb 2016	125,387
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 1.91 per share.	Directo	1,330,487	25 feb 2016	696,590
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.44 - 0.50 per share.	Indirecto	5,640	20 ago 2015	12,000
HOON RUSSELL A Officer		Directo		14 abr 2015	4,515
PAULSON THOMAS J Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	23 mar 2015	23,986
WU ROY J Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	23 mar 2015	19,296
NAJAFI RAMIN Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	23 mar 2015	46,033
SIECZKAREK MARK M. Director	Purchase at price 0.60 per share.	Directo	100,000	03 mar 2015	166,666
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.60 per share.	Indirecto	100,000	03 mar 2015	166,666
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.60 per share.	Directo	1,554,000	03 mar 2015	2,590,000
PAULSON THOMAS J Chief Financial Officer	Purchase at price 0.68 per share.	Directo	6,800	12 dic 2014	10,000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.65 per share.	Directo	32,500	12 dic 2014	50,000
STROMAN DAVID W Officer	Purchase at price 0.66 per share.	Directo	6,600	12 dic 2014	10,000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.60 per share.	Directo	12,000	11 dic 2014	20,000
PAULSON THOMAS J Chief Financial Officer	Purchase at price 0.67 per share.	Directo	6,700	09 dic 2014	10,000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.65 per share.	Directo	16,250	05 dic 2014	25,000
WICKS TONY D S Director	Sale at price 0.70 per share.	Directo	14,000	02 dic 2014	20,000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.71 per share.	Directo	12,780	02 dic 2014	18,000
WICKS TONY D S Director	Sale at price 0.69 per share.	Directo	6,900	01 dic 2014	10,000
SIECZKAREK MARK M. Director	Purchase at price 0.89 per share.	Directo	4,272	04 jun 2014	4,800
NAJAFI RAMIN Chief Executive Officer	Stock Gift at price 0.00 per share.	Indirecto	0	02 jun 2014	5,500
SIECZKAREK MARK M. Director	Purchase at price 0.88 per share.	Directo	22,000	19 may 2014	25,000
CHINA PIONEER PHARMA HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.99 per share.	Directo	64,414	13 may 2014	65,065
CHINA PIONEER PHARMA HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.99 per share.	Directo	114,946	12 may 2014	116,107
CHINA PIONEER PHARMA HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.99 per share.	Directo	315,640	09 may 2014	318,828
WICKS TONY D S Director	Conversion of Exercise of derivative security at price 0.56 per share.	Directo	29,120	14 abr 2014	52,000
DAILLEY ANTHONY Director	Conversion of Exercise of derivative security at price 0.56 per share.	Directo	5,040	17 mar 2014	9,000
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.14 per share.	Directo	5,700,000	02 dic 2013	5,000,000
CHINA PIONEER PHARMA HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.14 per share.	Indirecto	5,700,000	02 dic 2013	5,000,000
PIONEER PHARMA HONG KONG CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.14 per share.	Indirecto	5,700,000	02 dic 2013	5,000,000
CHINA PIONEER PHARMA HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.02 per share.	Directo	110,319	14 nov 2013	108,156
LI XINZHOU Beneficial Owner of more than 10% of a Class of Security	Sale at price 0.08 per share.	Directo	9,312	20 sept 2013	120,000
LI XINZHOU Officer of Subsidiary Company	Purchase at price 1.20 per share.	Directo	144,000	11 dic 2012	120,000
PAULSON THOMAS J Chief Financial Officer	Purchase at price 1.24 per share.	Directo	12,400	06 dic 2012	10,000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 1.24 per share.	Directo	24,800	06 dic 2012	20,000
STROMAN DAVID W Officer	Purchase at price 1.24 per share.	Directo	12,400	06 dic 2012	10,000
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.25 per share.	Directo	1,500,000	31 oct 2012	1,200,000
NAQU AREA PIONEER PHARMA CO LTD Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.25 per share.	Indirecto	1,500,000	31 oct 2012	1,200,000
LI XINZHOU Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.25 per share.	Indirecto	1,500,000	31 oct 2012	1,200,000
TUFTS ROBERT R Director	Conversion of Exercise of derivative security at price 0.56 per share.	Indirecto	15,960	27 sept 2012	28,500
LI XINZHOU Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.25 per share.	Indirecto	1,000,000	13 sept 2012	800,000
PAULSON THOMAS J Chief Financial Officer	Purchase at price 0.94 per share.	Directo	9,364	30 may 2012	10,000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.96 per share.	Directo	5,756	29 may 2012	6,000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.99 per share.	Directo	3,465	25 may 2012	3,500
FREIMAN PAUL EDWARD Director	Conversion of Exercise of derivative security at price 0.20 per share.	Indirecto	6,000	29 dic 2011	30,000
NAJAFI RAMIN Chief Executive Officer	Stock Award(Grant) at price 1.09 per share.	Directo	54,500	27 oct 2011	50,000
NAJAFI RAMIN Chief Executive Officer	Stock Award(Grant) at price 0.90 per share.	Directo	137,406	29 sept 2011	152,673
FREIMAN PAUL EDWARD Director	Purchase at price 0.84 per share.	Indirecto	2,520	12 sept 2011	3,000
PAULSON THOMAS J Chief Financial Officer	Purchase at price 0.86 per share.	Directo	3,010	26 ago 2011	3,500
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.85 per share.	Directo	8,500	16 ago 2011	10,000
TUFTS ROBERT R Director	Purchase at price 0.85 per share.	Indirecto	4,242	15 ago 2011	5,000
STROMAN DAVID W Officer	Purchase at price 1.01 per share.	Directo	10,100	16 jun 2011	10,000
KHOSROVI BEHZAD Officer	Purchase at price 1.63 - 1.65 per share.	Directo	1,644	27 may 2011	1,000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 1.59 per share.	Directo	797	27 may 2011	500
MCPHERSON T ALEX Director	Purchase at price 1.63 - 1.65 per share.	Indirecto	10,217	27 may 2011	6,200
NAJAFI RAMIN Chief Executive Officer	Purchase at price 1.60 per share.	Directo	1,597	26 may 2011	1,000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 1.67 - 1.74 per share.	Directo	4,371	24 may 2011	2,552
FREIMAN PAUL EDWARD Director	Sale at price 1.83 per share.	Indirecto	27,450	16 ago 2010	15,000
TUFTS ROBERT R Director	Conversion of Exercise of derivative security at price 2.02 per share.	Directo	36,679	04 ene 2010	18,158
TUFTS ROBERT R Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	10 dic 2009	302
DAILLEY ANTHONY Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	10 dic 2009	302
MCPHERSON T ALEX Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	10 dic 2009	603
HIXSON HARRY F JR Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	06 oct 2009	343
FREIMAN PAUL EDWARD Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	06 oct 2009	343
FREIMAN PAUL EDWARD Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	06 oct 2009	343
TUFTS ROBERT R Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	06 oct 2009	343
DAILLEY ANTHONY Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	06 oct 2009	686
MCPHERSON T ALEX Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	06 oct 2009	686
HIXSON HARRY F JR Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	15 sept 2009	1,459
HIXSON HARRY F JR Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	14 sept 2009	1,350
CASHION CHARLES J Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	14 sept 2009	1,350
FREIMAN PAUL EDWARD Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	14 sept 2009	1,350
WICKS TONY D S Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	14 sept 2009	1,350
TUFTS ROBERT R Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	14 sept 2009	1,350
DAILLEY ANTHONY Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	14 sept 2009	1,350
MCPHERSON T ALEX Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	14 sept 2009	1,350
DAILLEY ANTHONY Director	Conversion of Exercise of derivative security at price 0.56 per share.	Indirecto	5,600	03 sept 2009	10,000
CASHION CHARLES J Director	Purchase at price 1.90 per share.	Indirecto	1,900	31 ago 2009	1,000
TUFTS ROBERT R Director	Conversion of Exercise of derivative security at price 0.56 per share.	Indirecto	11,200	31 ago 2009	20,000
CASHION CHARLES J Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	28 ago 2009	1,428
FREIMAN PAUL EDWARD Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	28 ago 2009	1,428
WICKS TONY D S Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	28 ago 2009	1,428
NAJAFI RAMIN Chief Executive Officer	Purchase at price 1.92 per share.	Directo	1,920	28 ago 2009	1,000
TUFTS ROBERT R Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	28 ago 2009	1,428
DAILLEY ANTHONY Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	28 ago 2009	1,428
MCPHERSON T ALEX Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	28 ago 2009	1,428
HIXSON HARRY F JR Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	13 ago 2009	252
CASHION CHARLES J Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	13 ago 2009	504
TUFTS ROBERT R Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	13 ago 2009	252
HIXSON HARRY F JR Director	Purchase at price 2.33 per share.	Indirecto	58,250	11 jun 2009	25,000
FREIMAN PAUL EDWARD Director	Sale at price 2.33 per share.	Indirecto	58,250	11 jun 2009	25,000
HIXSON HARRY F JR Director	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	04 jun 2009	1,369

S&P 5005,079.44+43.75(+0.87%)

Dow Jones38,241.69+425.77(+1.13%)

Nasdaq15,865.69+207.87(+1.33%)

Russell 20002,011.57+37.66(+1.91%)

Petróleo79.25-2.68(-3.27%)

Oro2,330.90+28.00(+1.22%)

NovaBay Pharmaceuticals, Inc. (NBY)

Transacciones de miembros de la gerencia

Información confidencial de transacciones reportada (últimos dos años)

S&P 500
5,079.44
+43.75(+0.87%)

Dow Jones
38,241.69
+425.77(+1.13%)

Nasdaq
15,865.69
+207.87(+1.33%)

Russell 2000
2,011.57
+37.66(+1.91%)

Petróleo
79.25
-2.68(-3.27%)

Oro
2,330.90
+28.00(+1.22%)